Lindblom Christopher M 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Nov 27, 2012
Insider Transaction Report
Form 4
Lindblom Christopher M
Controller & Asst. Treasurer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2012-11-26−10,000→ 10,000 totalExercise: $14.33Exp: 2016-10-26→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2012-11-26−3,885→ 0 totalExercise: $9.80Exp: 2017-12-13→ Common Stock (3,885 underlying) - Sale
Common Stock
2012-11-26$25.73/sh−13,885$357,272→ 0 total - Exercise/Conversion
Common Stock
2012-11-26$14.33/sh+10,000$143,300→ 10,000 total - Exercise/Conversion
Common Stock
2012-11-26$9.80/sh+3,885$38,073→ 13,885 total
Holdings
- 2,158(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents 2,158 shares of Infinity Pharmaceuticals, Inc. common stock acquired under the Infinity Pharmaceuticals, Inc. 401(k) plan.
- [F2]This option was fully vested with respect to all 20,000 shares subject to the option as of the date hereof.
- [F3]This option was fully vested with respect to all 3,885 shares subject to the option as of the date hereof.